Traws Pharma, Inc.
Clinical trials sponsored by Traws Pharma, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug TRX-100 takes first step: safety check in healthy people Results expected Sep 2026 (estimated)
- New flu pill TRX-100 put to the test in human challenge trial Results expected Nov 2026 (estimated)
- New flu pill TRX-100 tested for safety and symptom relief Results expected Dec 2026 (estimated)
-
New pill 83-0060 passes first safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of an experimental oral drug called 83-0060 in 57 healthy adults aged 18 to 65. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The go…
Phase 1 • Sponsor: Traws Pharma, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New drug TRX-100 tested in healthy people for first time
Knowledge-focused CompletedThis early-stage study tested a single dose of the experimental drug TRX-100 in 66 healthy adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either TRX-100 or a placebo. The goal was to check for side effects and measure dru…
Phase 1 • Sponsor: Traws Pharma, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC